BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 123 filers reported holding BIOSCRIP INC in Q4 2014. The put-call ratio across all filers is 10.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $205,000 | -42.4% | 75,646 | -63.9% | 0.01% | -40.0% |
| Q1 2017 | $356,000 | +350.6% | 209,586 | +176.2% | 0.01% | +400.0% |
| Q4 2016 | $79,000 | +139.4% | 75,871 | +569.4% | 0.00% | +100.0% |
| Q3 2016 | $33,000 | -86.7% | 11,334 | -88.3% | 0.00% | -80.0% |
| Q2 2016 | $248,000 | +113.8% | 97,092 | +79.4% | 0.01% | +66.7% |
| Q1 2016 | $116,000 | -29.3% | 54,120 | -42.4% | 0.00% | 0.0% |
| Q4 2015 | $164,000 | +272.7% | 93,911 | +302.4% | 0.00% | +200.0% |
| Q3 2015 | $44,000 | -79.0% | 23,336 | -23.1% | 0.00% | -75.0% |
| Q3 2014 | $210,000 | +52.2% | 30,362 | +83.2% | 0.00% | +100.0% |
| Q2 2014 | $138,000 | +89.0% | 16,577 | +57.3% | 0.00% | +100.0% |
| Q1 2014 | $73,000 | -24.7% | 10,541 | -20.0% | 0.00% | 0.0% |
| Q4 2013 | $97,000 | -83.9% | 13,183 | -80.8% | 0.00% | -87.5% |
| Q3 2013 | $602,000 | – | 68,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |